Urethral Stricture Clinical Trial
Official title:
Endoscopic Buccal Mucosal Graft Urethroplasty or Bladder Neck Reconstruction
Study Objectives The current definitive treatment options for urethral stricture disease include endoscopic urethrotomy known as Direct Vision Internal Urethrotomy (DVIU) or open reconstruction known as urethroplasty (1-6). The purpose of this study is to determine feasibility of endoscopic-only repair of urethral stricture or bladder neck contracture using a combination of existing surgical techniques of internal urethrotomy (or bladder neck incision) augmented by buccal mucosal graft.
Background and Rationale There are two definitive treatment options for urethral strictures:
DVIU and open urethroplasty. DVIU is an endoscopic procedure considered to be minimally
invasive, but also with a high failure rate of 60-92%. The repeated DVIUs are reported to
have even higher failure rates. On the other hand, open urethroplasty, considered a gold
standard for reconstruction, is invasive, requires incision of the perineum or urethra,
leaves a life-long scar, and has long term success rates of 74-95%. The details of DVIU and
open urethroplasty are discussed below.
DVIU involves passing a cystoscope into the urethra to the level of stricture and incising
the stricture longitudinally to create a wide passage to the level of normal urethra on the
proximal side. The hope is to cut through the scar to the level of healthy underlying tissue
and in the process of healing to populate the cut surface with healthy urethral epithelium
(or at least to stabilize the scar in open configuration). In most cases, the scarring
recurs faster than epithelization and most strictures recur after DVIU within 7-8 months.
Studies show the strictures after traditional repeat DVIU are longer and require more
involved reconstruction than strictures in patients without prior instrumentation.
Open urethroplasty for urethral strictures or bladder neck contractures usually involves
longitudinal incision of the urethra (from outside in) and augmentation of the incised part
with a strip of harvested Buccal Mucosal Graft (BMG). The goal of the operation is to create
a wide urethral lumen for the patient to be able to pass urine without obstruction.
The first step of the procedure for DVIU and open reconstruction are nearly the same: a
longitudinal incision of the scarred portion of the urethra. The difference is in the second
part: covering the defect with buccal mucosal graft as in open urethroplasty vs leaving the
incision uncovered and exposed to passage of urine.
Investigators of this study hereby propose to combine the minimally invasive technique of
the DVIU with the technique of augmenting the incised stricture (or bladder neck
contracture) using buccal mucosal graft placed endoscopically by means of application of
liquid suspended graft. A similar, but more invasive technique was reported by Seith et al
in 2012 performed in 12 patients with the exception of need for small open perineal incision
for graft fixation. A purely endoscopic skin graft placement into urethra was reported by
Naude in 1998 in 53 patients with 95% success rate at 2 years follow up. While he has not
made actual incisions, his approach required percutaneous perineal needle placement for
graft delivery and a specialized device for graft delivery and graft fixation. The procedure
proposed for current trial is purely endoscopic with buccal graft placement and fixation
augmented by fibrin glue. This type of fibrin glue sealant is readily available and widely
used in General Surgery, Plastic Surgery and in Urology specifically for urethral
reconstruction). This will allow for significantly less invasive procedure, shorter
procedure time, absence of traditional perineal incision or needle puncture, and earlier
return home (same day vs 1-3 days), earlier catheter removal (5-7 days vs 21 days) and
earlier return to regular activities (1 week vs 6 weeks).
Overall, the aim is to improve the outcomes of traditional endoscopic procedure while
eliminating morbidity of the open reconstruction with added benefits of earlier
convalescence and health care savings from decreased surgical morbidity and shortened
hospital stay.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03572348 -
VeSpAR: Comparing Vessel-Sparing Anastomotic Repair and Transecting Anastomotic Repair in Isolated Short Bulbar Strictures.
|
N/A | |
Completed |
NCT02321670 -
Scandinavian Urethroplasty Study
|
N/A | |
Recruiting |
NCT05519566 -
The Accuracy of Pulsed Fluoroscopy Retrograde Urethrogram Vs the Traditional Retrograde Urethrogram In Diagnosing Urethral Stricture
|
N/A | |
Recruiting |
NCT04071925 -
9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease
|
||
Terminated |
NCT02551783 -
Dorsal vs. Ventral Buccal Graft Dorsal vs. Ventral Buccal Graft
|
N/A | |
Active, not recruiting |
NCT03270384 -
Re-establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease
|
N/A | |
Not yet recruiting |
NCT03258658 -
Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures
|
Phase 1 | |
Completed |
NCT03973619 -
Urethral Stricture: A Comparison Between Jugal or Labial Graft Urethroplasty
|
N/A | |
Recruiting |
NCT04965025 -
Multi-stage Urethroplasty With Augmentation Using a Dorsal Graft Inlay Technique Comparing Graft Use in First or Second Stage
|
N/A | |
Withdrawn |
NCT03851952 -
Re-Establishing Flow Via Drug Coated Balloon for the Treatment of Urethral Stricture Disease - Registry Study
|
N/A | |
Recruiting |
NCT04161365 -
Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Urethral Strictures
|
N/A | |
Completed |
NCT02948842 -
Clostridium Histolyticum Collagenase Injection for Urethral Disease
|
Phase 2 | |
Not yet recruiting |
NCT06384066 -
Mobile Health Application to Improve Patient Satisfaction After Urethroplasty
|
N/A | |
Completed |
NCT03859024 -
Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty
|
Phase 4 | |
Active, not recruiting |
NCT03499964 -
ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease
|
N/A | |
Terminated |
NCT02634619 -
A Study of Dorsal Versus Ventral Buccal Mucosa Graft Onlay for Bulbar Urethroplasty
|
N/A | |
Not yet recruiting |
NCT00918528 -
Effect of Mitomycin C on Urethral Stricture Recurrence After Internal Urethrotomy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06064968 -
Effectiveness of Intermittent Bladder Catheterization (IBC) in Reducing Recurrence of Urethral Stricture
|
N/A | |
Completed |
NCT05078788 -
Holmium Laser Uretherotomy in Combination With Intralesional Steroids in Bulbar Uretheral Stricture
|
N/A | |
Enrolling by invitation |
NCT03205670 -
Tissue-engineered Construct Based on Buccal Mucosa Cells and Matrix From Collagen and Polylactoglycolide Fibers
|
Early Phase 1 |